T. Rowe Price Group, Inc. · TROW · FY2026 Q1 · Calendar Q2 2026

T. Rowe Price Q1 2026: EPS Beats on ETF Strength, OHA Expansion

T. Rowe Price delivered a solid Q1 2026 with adjusted EPS up 13% year-over-year to $2.52, beating consensus of $2.33 by 8.2%. Revenue of $1.857 billion narrowly topped estimates. AUM stood at $1.71 trillion, down from $1.78 trillion at year-end 2025, as market depreciation and $13.7 billion of net outflows partially offset gross sales growth. The active ETF platform is gaining real traction: $2.8 billion of net inflows brought ETF AUM above $25 billion across 32 tickers. The OHA alternatives business scaled to $112 billion in assets with $30 billion in dry powder, expanding into wealth-distribution products. Management accelerated share repurchases to $340 million in the quarter. Guidance was maintained with expense growth projected at 3-6% above 2025 levels. The stock reacted positively, gaining 1.4% on the event day on volume 2.1x baseline, and drifted an additional 1.6% higher…

Reported Before market openNASDAQFinancial Services $25.47B market cap
100quality score

Company context

Snapshot as of publication

T. Rowe Price Group, Inc. operates as a publicly traded entity specializing in investment management. The firm extends its financial expertise to a diverse range of clients, including individual investors, institutional organizations, retirement benefit plans, and financial intermediaries. It is responsible for the establishment and ongoing management of both equity and fixed income mutual funds. The company's investment activities encompass public stock and bond markets worldwide. Employing a bottom-up methodology, the firm integrates both fundamental and quantitative analysis, leveraging insights from both internal research capabilities and external sources for its investment decisions. A core tenet of its investment philosophy is socially responsible investing, with a significant emphasis on environmental, social, and governance (ESG) factors. Furthermore, T.…

Earnings scorecard

Reported versus consensus
Reported EPS $2.52 Consensus $2
EPS surprise +8.2% Reported versus consensus
Reported revenue $1.86B Consensus $1.85B
Revenue surprise +0.1% Reported versus consensus

Earnings History

Estimate Beat Miss Match
TROW REVENUE earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 estimate $2B Q4 '23 actual $2B, beat Q1 '24 estimate $2B Q1 '24 actual $2B, beat Q2 '24 estimate $2B Q2 '24 actual $2B, miss Q3 '24 estimate $2B Q3 '24 actual $2B, miss Q2 '25 estimate $2B Q2 '25 actual $2B, miss Q3 '25 estimate $2B Q3 '25 actual $2B, beat Q4 '25 estimate $2B Q4 '25 actual $2B, beat Q1 '26 estimate $2B Q1 '26 actual $2B, beat Q2 '26 estimate $2B Q3 '26 estimate $2B Q4 '26 estimate $2B Q1 '27 estimate $2B

Analyst Consensus ?

ConsensusHold37 ratings
Bullish821.6%
Neutral2362.2%
Bearish616.2%

Analyst 52W Price Targets

$119.28Current
$87Low
$119.4Average
$215High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
TD Cowen Hold HoldMaintainJul 20, 2026
Barclays Underweight UnderweightMaintainJul 14, 2026
Keefe, Bruyette & Woods Market Perform Market PerformMaintainJul 10, 2026
Evercore ISI Group In Line In LineMaintainJul 10, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJun 26, 2026
JP Morgan Underweight UnderweightMaintainApr 24, 2026
BMO Capital Market Perform Market PerformMaintainApr 10, 2026
Goldman Sachs Sell SellMaintainApr 7, 2026
Show 29 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $119.28. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Morgan StanleyAnalyst unavailable$116$120.39 -2.7%Jul 29, 2026
BarclaysBenjamin Budish$108$113.65 -9.5%Jul 14, 2026
Evercore ISIAnalyst unavailable$121$119.04 +1.4%Jul 10, 2026
Morgan StanleyMichael Cyprys$109$109.08 -8.6%Jun 26, 2026
Evercore ISIGlenn Schorr$111$106.29 -6.9%Jun 8, 2026
Evercore ISIGlenn Schorr$104$103.71 -12.8%May 1, 2026
BarclaysBenjamin Budish$89$102.88 -25.4%May 1, 2026
Morgan StanleyMichael Cyprys$105$99.38 -12.0%Apr 27, 2026
BarclaysAnalyst unavailable$87$95.75 -27.1%Apr 17, 2026
Evercore ISIGlenn Schorr$96$91.97 -19.5%Apr 10, 2026
See 30 more

Track every rating change on TROW the moment it posts. Free to start.

Start free

Market reaction

prior-close to event-session close
Stock move +2.4% Event window
SPY move +1.0% Same window
Abnormal move +1.4% Stock minus SPY
Volume 2.1× Versus trailing sessions
Subsequent drift +1.6% Up to 20 sessions
TROWSPY benchmark

Follow TROW with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

Compared to the prior quarter, net outflows narrowed sharply from $56.9 billion to $13.7 billion, though AUM still declined from $1.78 trillion to $1.71 trillion reflecting market depreciation. ETF momentum accelerated with $2.8 billion of net inflows and total ETF AUM crossing $25 billion across 32 tickers. OHA alternatives grew assets to $112 billion with $30 billion in dry powder, up from $88 billion at year-end 2024. Share repurchases accelerated to $340 million in Q1. New product launches were announced including the OFlex multi-strategy interval fund, a new target-date sister series, and the firm's first European ETFs. Geopolitical risk from the Iran conflict emerged as a new concern. The crypto ETF and tokenization initiatives highlighted in the prior quarter were not prominently featured this period.

Guidance delta

Guidance was maintained. The 2026 expense growth outlook remains at 3-6% above 2025 levels, unchanged from the prior quarter. Management tone remained confident, and no new financial guidance metrics were introduced or revised.

Key takeaways

  • Adjusted EPS of $2.52 beat consensus of $2.33 by 8.2%, up 13% year-over-year.
  • AUM of $1.71 trillion, down from $1.78 trillion at year-end 2025, as market depreciation and $13.7 billion of net outflows offset gross sales.
  • Active ETF platform added $2.8 billion in net inflows, pushing ETF AUM above $25 billion across 32 tickers.
  • OHA alternatives business grew to $112 billion in assets with $30 billion in dry powder, launching new wealth-focused products including the OCREDIT BDC and OFlex interval fund.
  • Share repurchases accelerated to $340 million in the quarter.
  • Equity mutual fund outflows of $13.7 billion persisted, though multi-asset, fixed income, and alternatives saw net inflows.

Management priorities

  • Expand active ETF platform with new tickers and a planned European ETF launch later in 2026.
  • Scale OHA alternatives into wealth distribution with the OCREDIT BDC and OFlex multi-strategy interval fund.
  • Activate the First Abu Dhabi Bank partnership in mid-2026 for Middle East distribution.
  • Continue disciplined expense management within the 3-6% growth range.
  • Introduce a new target-date sister series later in the year.
  • Evaluate opportunistic M&A and further product development.

Related earnings events

Financial Services

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-07-30T19:12:04.122840+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T19:12:04.120028+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.